Oct 03, 2017 11:32 am UTC| Business
WALTHAM, Mass., Oct. 03, 2017 -- Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, announced the closing of its...
Oct 03, 2017 11:32 am UTC| Business
MENLO PARK, Calif., Oct. 03, 2017 -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), today announced that the human genetics community is demonstrating increasing recognition of the value of Single Molecule,...
Oct 03, 2017 11:19 am UTC| Business
Syracuse, NY, Oct. 03, 2017 -- Anaren IoT Group today announced a new strategic partnership with NXP® Semiconductors that will see the integration of Atmosphere, Anaren’s leading IoT Creation Environment, into NXP’s...
Nlyte Introduces Comprehensive Discovery Solution for Heterogeneous Infrastructure Environments
Oct 03, 2017 11:10 am UTC| Business
SAN MATEO, Calif., Oct. 03, 2017 -- Nlyte Software, the leading data center infrastructure management (DCIM) software company, today announced the release of Nlyte Discovery. The new full-solution application set...
Oct 03, 2017 11:05 am UTC| Business
ORLANDO, Fla., Oct. 03, 2017 -- MEDITE Cancer Diagnostics, Inc. (OTCQB:MDIT) (the “Company”), specializing in the development, manufacturing and marketing of molecular biomarkers and premium medical devices for...
Oct 03, 2017 11:01 am UTC| Business
VANCOUVER, British Columbia, Oct. 03, 2017 -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce it has reached a definitive agreement with Global Damon Pharma (“GD...
Oct 03, 2017 11:00 am UTC| Business
BEKINDA®i 12 mg Phase II study successfully met its primary endpoint, improving primary efficacy outcome of stool consistency by an absolute difference of 19.4% vs. placebo and comparing favorably with previously reported...